NF1 and cancer: NF1 somatic variants are rare in primary cancers; are associated with poor prognosis and increased risk of recurrence [50]; have a high incidence of contralateral BC, poor survival [51], and BC progression; and contribute to endocrine therapy resistance [52,53].